The latest data point for Q1'26 shows R&D Expenses at $0, while SG&A Expenses reached $851.5M, resulting in total operating expenses of $851.5M for the quarter. From Q2'23 to Q1'26, R&D Expenses remained consistently at $0 across all periods, indicating no reported spending in this category. In contrast, SG&A Expenses exhibited a steady upward trend, increasing from $367.8M in Q2'23 to $851.5M in Q1'26, reflecting an overall growth of approximately 131% and driving the total operating expenses higher without any significant declines or volatility. This pattern suggests expanding administrative and selling costs, potentially tied to business scaling, while the absence of R&D allocation may highlight a focus on other operational priorities.